Mayuresh S Korgaonkar1, May Erlinger2, Isabella A Breukelaar2, Philip Boyce3, Philip Hazell3, Cassandra Antees2, Sheryl Foster4, Stuart M Grieve5, Lavier Gomes6, Leanne M Williams7, Anthony W F Harris8, Gin S Malhi9. 1. Brain Dynamics Centre, Westmead Institute for Medical Research, The University of Sydney, New South Wales, Australia; Discipline of Psychiatry, University of Sydney School of Medicine, New South Wales, Australia. Electronic address: M.Korgaonkar@sydney.edu.au. 2. Brain Dynamics Centre, Westmead Institute for Medical Research, The University of Sydney, New South Wales, Australia. 3. Discipline of Psychiatry, University of Sydney School of Medicine, New South Wales, Australia. 4. Department of Radiology, Westmead Hospital, Westmead, New South Wales, Australia; Discipline of Medical Radiation Sciences, Faculty of Health Science, The University of Sydney, New South Wales, Australia. 5. Sydney Translational Imaging Laboratory, Heart Research Institute, Charles Perkins Centre and University of Sydney School of Medicine, New South Wales, Australia; Department of Radiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. 6. Department of Radiology, Westmead Hospital, Westmead, New South Wales, Australia. 7. Brain Dynamics Centre, Westmead Institute for Medical Research, The University of Sydney, New South Wales, Australia; Psychiatry and Behavioral Sciences, Stanford University, Stanford, Palo Alto, California; Sierra-Pacific Mental Illness Research, Education, and Clinical Center, Palo Alto Veterans Affairs Health Care System, Palo Alto, California. 8. Brain Dynamics Centre, Westmead Institute for Medical Research, The University of Sydney, New South Wales, Australia; Discipline of Psychiatry, University of Sydney School of Medicine, New South Wales, Australia. 9. Discipline of Psychiatry, University of Sydney School of Medicine, New South Wales, Australia; Clinical Assessment Diagnostic Evaluation (CADE) Clinic, Department of Psychiatry, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Abstract
BACKGROUND: Mechanistically based neural markers, such as amygdala reactivity, offer one approach to addressing the challenges of differentiating bipolar and unipolar depressive disorders independently from mood state and acute symptoms. Although emotion-elicited amygdala reactivity has been found to distinguish patients with bipolar depression from patients with unipolar depression, it remains unknown whether this distinction is traitlike and present in the absence of an acutely depressed mood. We addressed this gap by investigating patients with bipolar disorder (BP) and unipolar major depressive disorder (MDD) in remission. METHODS: Supraliminal and subliminal processing of faces exhibiting threat, sad, happy, and neutral emotions during functional magnetic resonance imaging was completed by 73 participants (23 BP patients and 25 MDD patients matched for age and gender, number of depressive episodes and severity; 25 age- and gender-matched healthy control subjects). We compared groups for activation and connectivity for the amygdala. RESULTS: BP patients had lower left amygdala activation than MDD patients during supraliminal and subliminal threat, sad, and neutral emotion processing and for subliminal happy faces. BP patients also exhibited lower amygdala connectivity to the insula and hippocampus for threat and to medial orbitofrontal cortex for happy supraliminal and subliminal processing. BP patients also demonstrated greater amygdala-insula connectivity for sad supraliminal and subliminal face processing. Both patient groups were distinct from control subjects across several measures for activation and connectivity. CONCLUSIONS: Independent of valence or level of emotional awareness, amygdala activation and connectivity during facial emotion processing can distinguish BP patients and MDD patients. These findings provide evidence that this neural substrate could be a potential trait marker to differentiate these two disorders largely independent of illness state.
BACKGROUND: Mechanistically based neural markers, such as amygdala reactivity, offer one approach to addressing the challenges of differentiating bipolar and unipolar depressive disorders independently from mood state and acute symptoms. Although emotion-elicited amygdala reactivity has been found to distinguish patients with bipolar depression from patients with unipolar depression, it remains unknown whether this distinction is traitlike and present in the absence of an acutely depressed mood. We addressed this gap by investigating patients with bipolar disorder (BP) and unipolar major depressive disorder (MDD) in remission. METHODS: Supraliminal and subliminal processing of faces exhibiting threat, sad, happy, and neutral emotions during functional magnetic resonance imaging was completed by 73 participants (23 BP patients and 25 MDDpatients matched for age and gender, number of depressive episodes and severity; 25 age- and gender-matched healthy control subjects). We compared groups for activation and connectivity for the amygdala. RESULTS: BP patients had lower left amygdala activation than MDDpatients during supraliminal and subliminal threat, sad, and neutral emotion processing and for subliminal happy faces. BP patients also exhibited lower amygdala connectivity to the insula and hippocampus for threat and to medial orbitofrontal cortex for happy supraliminal and subliminal processing. BP patients also demonstrated greater amygdala-insula connectivity for sad supraliminal and subliminal face processing. Both patient groups were distinct from control subjects across several measures for activation and connectivity. CONCLUSIONS: Independent of valence or level of emotional awareness, amygdala activation and connectivity during facial emotion processing can distinguish BP patients and MDDpatients. These findings provide evidence that this neural substrate could be a potential trait marker to differentiate these two disorders largely independent of illness state.
Authors: Angus C Burns; Richa Saxena; Céline Vetter; Andrew J K Phillips; Jacqueline M Lane; Sean W Cain Journal: J Affect Disord Date: 2021-08-27 Impact factor: 4.839
Authors: Valentina Lorenzetti; Sergi G Costafreda; Rachael M Rimmer; Mark M Rasenick; Lauren B Marangell; Cynthia H Y Fu Journal: J Affect Disord Date: 2020-01-27 Impact factor: 4.839
Authors: Chieh-En J Tseng; Tonya M Gilbert; Mary C Catanese; Baileigh G Hightower; Amy T Peters; Anjali J Parmar; Minhae Kim; Changning Wang; Joshua L Roffman; Hannah E Brown; Roy H Perlis; Nicole R Zürcher; Jacob M Hooker Journal: Transl Psychiatry Date: 2020-07-08 Impact factor: 6.222
Authors: Sabina Rai; Kristi R Griffiths; Isabella A Breukelaar; Ana R Barreiros; Wenting Chen; Philip Boyce; Philip Hazell; Sheryl L Foster; Gin S Malhi; Anthony W F Harris; Mayuresh S Korgaonkar Journal: Transl Psychiatry Date: 2021-10-23 Impact factor: 6.222
Authors: Anna Manelis; Yaroslav O Halchenko; Lisa Bonar; Richelle S Stiffler; Skye Satz; Rachel Miceli; Cecile D Ladouceur; Genna Bebko; Satish Iyengar; Holly A Swartz; Mary L Phillips Journal: Transl Psychiatry Date: 2022-10-11 Impact factor: 7.989